{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:02:46Z","timestamp":1791223366534,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["N01-AI-30,025"],"award-info":[{"award-number":["N01-AI-30,025"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["N01-AI-30,025"],"award-info":[{"award-number":["N01-AI-30,025"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["N01-AI-30,025"],"award-info":[{"award-number":["N01-AI-30,025"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.clp.2011.12.004","type":"journal-article","created":{"date-parts":[[2012,1,28]],"date-time":"2012-01-28T14:49:30Z","timestamp":1327762170000},"page":"69-81","source":"Crossref","is-referenced-by-count":36,"title":["The Use of Antiviral Drugs During the Neonatal Period"],"prefix":"10.1016","volume":"39","author":[{"given":"Richard J.","family":"Whitley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clp.2011.12.004_bib1","series-title":"Principles and practice of pediatric infectious diseases","first-page":"1470","article-title":"Antiviral agents","author":"Kimberlin","year":"2008"},{"key":"10.1016\/j.clp.2011.12.004_bib2","series-title":"Laboratory diagnosis of viral infections","first-page":"519","article-title":"Antiviral drugs","author":"Rha","year":"2009"},{"issue":"2","key":"10.1016\/j.clp.2011.12.004_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/jama.289.2.203","article-title":"Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant","volume":"289","author":"Brown","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2011.12.004_bib4","series-title":"Infections in the central nervous system","first-page":"123","article-title":"Herpes simplex virus","author":"Whitley","year":"2004"},{"issue":"2","key":"10.1016\/j.clp.2011.12.004_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1542\/peds.108.2.223","article-title":"Natural history of neonatal herpes simplex virus infections in the acyclovir era","volume":"108","author":"Kimberlin","year":"2001","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.clp.2011.12.004_bib6","first-page":"11","article-title":"Management of HSV encephalitis in adults and neonates: diagnosis, prognosis and treatment","volume":"14","author":"Kimberlin","year":"2007","journal-title":"Herpes"},{"issue":"1","key":"10.1016\/j.clp.2011.12.004_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0022-3476(87)80298-6","article-title":"Intrauterine herpes simplex virus infections","volume":"110","author":"Hutto","year":"1987","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2011.12.004_bib8","series-title":"Infectious diseases of the fetus and newborn infants","first-page":"282","article-title":"Herpes simplex virus infections","author":"Whitley","year":"1990"},{"issue":"1","key":"10.1016\/j.clp.2011.12.004_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/infdis\/158.1.109","article-title":"Changing presentation of herpes simplex virus infection in neonates","volume":"158","author":"Whitley","year":"1988","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.clp.2011.12.004_bib10","series-title":"Clinical virology","first-page":"375","article-title":"Herpes simplex viruses","author":"Whitley","year":"2004"},{"issue":"7","key":"10.1016\/j.clp.2011.12.004_bib11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJM199102143240703","article-title":"A\u00a0controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection","volume":"324","author":"Whitley","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.clp.2011.12.004_bib12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1542\/peds.108.2.230","article-title":"Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections","volume":"108","author":"Kimberlin","year":"2001","journal-title":"Pediatrics"},{"issue":"14","key":"10.1016\/j.clp.2011.12.004_bib13","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJMoa1003509","article-title":"Impact of oral acyclovir suppression on neurodevelopmental outcomes and skin recurrences following neonatal herpes simplex virus disease","volume":"365","author":"Kimberlin","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2011.12.004_bib14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.7326\/0003-4819-76-3-112-6-416","article-title":"Herpes simplex virus resistant to acyclovir. A study in a tertiary care center","volume":"112","author":"Englund","year":"1990","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.clp.2011.12.004_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.7.1.1","article-title":"\u201cThe end of innocence\u201d revisited: resistance of herpesviruses to antiviral drugs","volume":"7","author":"Field","year":"1994","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.clp.2011.12.004_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/adc.70.2.133","article-title":"Acyclovir resistant varicella zoster and HIV infection","volume":"70","author":"Lyall","year":"1994","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.clp.2011.12.004_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1386-6532(02)00263-9","article-title":"Herpes simplex virus resistance to antiviral drugs","volume":"26","author":"Morfin","year":"2003","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.clp.2011.12.004_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2165\/00003495-199447010-00009","article-title":"Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy","volume":"47","author":"Wagstaff","year":"1994","journal-title":"Drugs"},{"issue":"1A","key":"10.1016\/j.clp.2011.12.004_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0002-9343(82)90090-0","article-title":"Effect of renal failure on the pharmacokinetics of acyclovir","volume":"73","author":"Laskin","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.clp.2011.12.004_bib20","series-title":"Clinical virology","first-page":"217","article-title":"Anti-hepatitis virus and anti-respiratory virus agents","author":"Yin","year":"2009"},{"issue":"1A","key":"10.1016\/j.clp.2011.12.004_bib21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0002-9343(82)90091-2","article-title":"Influence of hemodialysis on acyclovir pharmacokinetics in patients with chronic renal failure","volume":"73","author":"Krasny","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.clp.2011.12.004_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00006454-199603000-00014","article-title":"Administration of oral acyclovir suppressive therapy following neonatal herpes simplex virus disease limited to the skin, eyes, and mouth: results of a phase I\/II trial","volume":"15","author":"Kimberlin","year":"1996","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.clp.2011.12.004_bib23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/clinids\/21.2.435","article-title":"Delirium associated with acyclovir treatment in a patient with renal failure","volume":"21","author":"Revankar","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2011.12.004_bib24","series-title":"Clinical virology","first-page":"433","article-title":"Cytomegalovirus","author":"Griffiths","year":"2002"},{"issue":"9","key":"10.1016\/j.clp.2011.12.004_bib25","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/508173","article-title":"Seroprevalence of cytomegalovirus infection in the United States, 1988-1994","volume":"43","author":"Staras","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.clp.2011.12.004_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/clinids\/13.2.315","article-title":"Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease","volume":"13","author":"Demmler","year":"1991","journal-title":"Rev Infect Dis"},{"issue":"3","key":"10.1016\/j.clp.2011.12.004_bib27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0022-3476(87)80451-1","article-title":"Early clinical manifestations and intellectual outcome in children with symptomatic congenital cytomegalovirus infection","volume":"111","author":"Conboy","year":"1987","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.clp.2011.12.004_bib28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev Med Virol"},{"issue":"1","key":"10.1016\/j.clp.2011.12.004_bib29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.spid.2004.09.011","article-title":"Congenital cytomegalovirus infection: outcome and diagnosis","volume":"16","author":"Ross","year":"2005","journal-title":"Semin Pediatr Infect Dis"},{"key":"10.1016\/j.clp.2011.12.004_bib30","series-title":"Infections of the central nervous system","first-page":"159","article-title":"Cytomegalovirus","author":"Griffiths","year":"2004"},{"issue":"12","key":"10.1016\/j.clp.2011.12.004_bib31","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1086\/324345","article-title":"Cytomegalovirus infection of extremely low-birth weight infants via breast milk","volume":"33","author":"Maschmann","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2011.12.004_bib32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1542\/peds.79.1.76","article-title":"Infant pneumonitis associated with cytomegalovirus, chlamydia, pneumocystis, and ureaplasma","volume":"79","author":"Brasfield","year":"1987","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2011.12.004_bib33","first-page":"383","article-title":"Cytomegalovirus infection in the human placenta: maternal immunity and developmentally regulated receptors on trophoblasts converge","volume":"325","author":"Pereira","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"issue":"5","key":"10.1016\/j.clp.2011.12.004_bib34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0196-0709(90)90057-3","article-title":"Human cytomegalovirus labyrinthitis","volume":"11","author":"Strauss","year":"1990","journal-title":"Am J Otolaryngol"},{"issue":"1","key":"10.1016\/j.clp.2011.12.004_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00005072-198101000-00002","article-title":"Cytomegalovirus labyrinthitis in an infant: morphological, virological, and immunofluorescent studies","volume":"40","author":"Davis","year":"1981","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"1","key":"10.1016\/j.clp.2011.12.004_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(03)00192-6","article-title":"Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial","volume":"143","author":"Kimberlin","year":"2003","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2011.12.004_bib37","unstructured":"Oliver S, Cloud G, S\u00e1nchez P, et\u00a0al. Effect of ganciclovir (GCV) therapy on neurodevelopmental outcomes in symptomatic congenital cytomegalovirus (CMV) infections involving the central nervous system (CNS): a randomized, controlled study. Society for Pediatric Research (SPR) Annual Meeting. San Francisco, CA, April 29, 2006. p. [abstract: 752908]."},{"key":"10.1016\/j.clp.2011.12.004_bib38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2165\/00003495-199448030-00009","article-title":"Ganciclovir: an update of its therapeutic use in cytomegalovirus infection","volume":"48","author":"Markham","year":"1994","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.clp.2011.12.004_bib39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1386-6532(99)00029-3","article-title":"Management of allogeneic bone marrow transplant recipients at risk for cytomegalovirus disease using a surveillance bronchoscopy and prolonged pre-emptive ganciclovir therapy","volume":"13","author":"Reddy","year":"1999","journal-title":"J\u00a0Clin Virol"},{"issue":"5","key":"10.1016\/j.clp.2011.12.004_bib40","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1210\/jcem-72-5-1130","article-title":"Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism","volume":"72","author":"Jacobson","year":"1991","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.clp.2011.12.004_bib41","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1086\/317600","article-title":"Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials Group","volume":"182","author":"Frenkel","year":"2000","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.clp.2011.12.004_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/clpt.1993.4","article-title":"Linear Single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections","volume":"53","author":"Trang","year":"1993","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.clp.2011.12.004_bib43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0272-6386(12)80253-8","article-title":"Pharmacokinetics of ganciclovir in a patient undergoing hemodialysis","volume":"17","author":"Swan","year":"1991","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.clp.2011.12.004_bib44","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1345\/aph.1A393","article-title":"Valganciclovir: an advance in cytomegalovirus therapeutics","volume":"36","author":"Cocohoba","year":"2002","journal-title":"Ann Pharmacother"},{"issue":"8","key":"10.1016\/j.clp.2011.12.004_bib45","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/00912709922008452","article-title":"Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects","volume":"39","author":"Jung","year":"1999","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.clp.2011.12.004_bib46","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0026-895X(25)08828-5","article-title":"Intracellular metabolism of the antiherpes agents (S)-1-{3-hydroxy-2-(phosphonylmethoxy)propyl}cytosine","volume":"41","author":"Ho","year":"1992","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.clp.2011.12.004_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/(SICI)1099-1654(199709)7:3<145::AID-RMV196>3.0.CO;2-0","article-title":"Clinical uses of cidofovir","volume":"7","author":"Safrin","year":"1997","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.clp.2011.12.004_bib48","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1128\/JVI.68.7.4427-4431.1994","article-title":"Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir","volume":"68","author":"Lurain","year":"1994","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.clp.2011.12.004_bib49","unstructured":"Cherrington JM, Miner R, Allen SJ, et\u00a0al. Sensitivities of human cytomegalovirus (HCMV) clinical isolates to cidofovir. Eighth International Conference on Antiviral Research. Santa Fe (New Mexico); 1995."},{"key":"10.1016\/j.clp.2011.12.004_bib50","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-126-4-199702150-00002","article-title":"Cidofovir (HPMPC) for the treatment of cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial","volume":"126","author":"The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clp.2011.12.004_bib51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-126-4-199702150-00001","article-title":"Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS: a randomized, controlled trial","volume":"126","author":"Lalezari","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clp.2011.12.004_bib52","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/infdis\/170.3.570","article-title":"Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl)-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS","volume":"170","author":"Lalezari","year":"1994","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.clp.2011.12.004_bib53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0166-3542(00)00064-4","article-title":"Juvenile onset recurrent respiratory papillomatosis: possibilities for successful antiviral therapy","volume":"45","author":"Kimberlin","year":"2000","journal-title":"Antiviral Res"},{"issue":"10","key":"10.1016\/j.clp.2011.12.004_bib54","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archotol.125.10.1143","article-title":"Intralesional cidofovir for recurrent respiratory papillomatosis in children","volume":"125","author":"Pransky","year":"1999","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clp.2011.12.004_bib55","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1128\/AAC.39.6.1247","article-title":"Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients","volume":"39","author":"Cundy","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clp.2011.12.004_bib56","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/infdis\/171.4.788","article-title":"(S)-1{3-hydroxy-2-(phosphonylmethoxy)propyl}cytosine (cidofoviir): results of a phase I\/II study of a novel antiviral nucleotide analogue","volume":"171","author":"Lalezari","year":"1995","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.clp.2011.12.004_bib57","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00003495-199448020-00007","article-title":"Foscarnet: a reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infectious","volume":"48","author":"Wagstaff","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.clp.2011.12.004_bib58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/infdis\/169.1.193","article-title":"Foscarnet-resistant herpes simplex virus infection in patients with AIDS","volume":"169","author":"Safrin","year":"1994","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.clp.2011.12.004_bib59","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/clinids\/18.4.570","article-title":"Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC)","volume":"18","author":"Snoeck","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2011.12.004_bib60","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/infdis\/163.6.1348","article-title":"Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS","volume":"163","author":"Jacobson","year":"1991","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.clp.2011.12.004_bib61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-115-1-19","article-title":"Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella zoster virus infection","volume":"115","author":"Safrin","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clp.2011.12.004_bib62","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJM199201233260401","article-title":"Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis","volume":"326","author":"Studies of Ocular Complications of AIDS Research Group","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clp.2011.12.004_bib63","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJM199108223250805","article-title":"A\u00a0controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome","volume":"325","author":"Safrin","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.clp.2011.12.004_bib64","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/infdis\/164.4.785","article-title":"Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring","volume":"164","author":"MacGregor","year":"1991","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.clp.2011.12.004_bib65","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000167987","article-title":"Foscarnet nephrotoxicity: mechanism, incidence and prevention","volume":"9","author":"Deray","year":"1989","journal-title":"Am J Nephrol"}],"updated-by":[{"DOI":"10.1016\/j.clp.2015.04.003","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000}}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009551081100131X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009551081100131X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T10:27:13Z","timestamp":1742380033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009551081100131X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S009551081100131X"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2011.12.004","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.clp.2015.04.003","asserted-by":"object"}]},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}